Phreesia Class Action Lawsuit Filed
Analysis based on 6 articles · First reported May 19, 2026 · Last updated Jun 05, 2026
The market is impacted by the decline in Phreesia's stock price, which fell by approximately 27% following the announcement of reduced revenue growth projections. This event creates uncertainty for investors in Phreesia and highlights the risks associated with companies providing allegedly misleading financial guidance.
The Gross Law Firm has issued a notice to shareholders of Phreesia, Inc. (NYSE: PHR) regarding a pending class action lawsuit. The lawsuit alleges that Phreesia provided materially false and misleading statements to investors between May 8, 2025, and March 30, 2026. These statements allegedly concealed the true state of Phreesia's slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in its Network Solutions segment. On March 30, 2026, Phreesia announced significantly reduced revenue growth projections for fiscal year 2027, attributing the shortfall to macroeconomic factors and weaker marketing commitments. Following this news, Phreesia's common stock declined by about 27%, from $11.41 to $8.38 per share. The deadline for shareholders to seek lead plaintiff appointment is July 13, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard